Dr. Michael Savetsky, MD
NPI: 1255598819
Total Payments
$66,648
2024 Payments
$791.07
Companies
23
Transactions
281
Medicare Patients
1,478
Medicare Billing
$119,399
Payment Breakdown by Category
Other$30,810 (46.2%)
Consulting$25,255 (37.9%)
Food & Beverage$7,632 (11.5%)
Travel$2,758 (4.1%)
Education$192.98 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,900 | 11 | 44.9% |
| Consulting Fee | $25,255 | 25 | 37.9% |
| Food and Beverage | $7,632 | 232 | 11.5% |
| Travel and Lodging | $2,758 | 8 | 4.1% |
| Honoraria | $909.85 | 3 | 1.4% |
| Education | $192.98 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EyePoint Pharmaceuticals US, Inc. | $41,853 | 54 | $0 (2021) |
| Oyster Point Pharma, Inc. | $9,987 | 18 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $6,138 | 34 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $2,530 | 9 | $0 (2024) |
| Shire North American Group Inc | $1,011 | 51 | $0 (2019) |
| NotalVision | $909.85 | 3 | $0 (2017) |
| TissueTech, Inc. | $668.30 | 6 | $0 (2018) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $597.65 | 26 | $0 (2024) |
| Alcon Vision LLC | $452.39 | 9 | $0 (2023) |
| Allergan, Inc. | $319.18 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $791.07 | 26 | Tarsus Pharmaceuticals, Inc. ($295.19) |
| 2023 | $390.35 | 21 | Horizon Therapeutics plc ($183.37) |
| 2022 | $10,433 | 32 | Oyster Point Pharma, Inc. ($9,969) |
| 2021 | $5,182 | 15 | EyePoint Pharmaceuticals US, Inc. ($2,714) |
| 2020 | $13,039 | 19 | EyePoint Pharmaceuticals US, Inc. ($12,886) |
| 2019 | $30,641 | 61 | EyePoint Pharmaceuticals US, Inc. ($26,253) |
| 2018 | $3,892 | 67 | Mallinckrodt LLC ($2,194) |
| 2017 | $2,279 | 40 | NotalVision ($909.85) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: SOLUTION/ DROPS | ||||||
| 12/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $33.84 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/09/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $55.10 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/24/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/13/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $64.64 | General |
| Category: Ophthalmology | ||||||
| 09/04/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/19/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 07/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $2.77 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/29/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/07/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $129.24 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/05/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 05/03/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Ophthalmology | ||||||
| 04/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/02/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/18/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/16/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 03/05/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/27/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/23/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 01/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Ophthalmology | ||||||
| 01/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 40 | 40 | $12,610 | $3,498 |
| 2022 | 8 | 338 | 417 | $62,970 | $15,827 |
| 2021 | 14 | 1,056 | 1,512 | $321,780 | $95,749 |
| 2020 | 2 | 44 | 48 | $9,100 | $4,325 |
Total Patients
1,478
Total Services
2,017
Medicare Billing
$119,399
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $9,250 | $2,504 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 14 | $3,360 | $994.23 | 29.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 122 | 138 | $24,150 | $6,089 | 25.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 48 | 48 | $9,600 | $3,158 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $7,800 | $2,418 | 31.0% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 32 | 32 | $4,480 | $1,380 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $3,750 | $1,013 | 27.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 40 | 76 | $6,880 | $868.27 | 12.6% |
| 92134 | Imaging of retina | Office | 2022 | 29 | 55 | $4,960 | $714.13 | 14.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 26 | 27 | $1,350 | $186.19 | 13.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 225 | 416 | $72,800 | $32,426 | 44.5% |
| 66984 | Removal of cataract with insertion of lens, simple | Facility | 2021 | 25 | 34 | $102,600 | $16,118 | 15.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 132 | 133 | $33,250 | $11,190 | 33.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 67 | 67 | $20,100 | $8,788 | 43.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 75 | 75 | $15,000 | $6,810 | 45.4% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 111 | 119 | $16,660 | $6,607 | 39.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 120 | 242 | $21,840 | $3,765 | 17.2% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 71 | 150 | $13,600 | $2,449 | 18.0% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 23 | 23 | $4,600 | $2,397 | 52.1% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Office | 2021 | 48 | 49 | $4,410 | $1,225 | 27.8% |
| 76519 | Ultrasound of eye for determination of lens power | Office | 2021 | 24 | 38 | $5,260 | $1,143 | 21.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 17 | $3,825 | $988.45 | 25.8% |
| 92025 | Computerized mapping of corneal curvature | Office | 2021 | 33 | 60 | $3,385 | $965.82 | 28.5% |
| 76514 | Ultrasound of corneal structure and measurement | Office | 2021 | 87 | 89 | $4,450 | $878.54 | 19.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 26 | 26 | $5,250 | $2,819 | 53.7% |
About Dr. Michael Savetsky, MD
Dr. Michael Savetsky, MD is a Cornea and External Diseases Specialist healthcare provider based in Culver City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1255598819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Savetsky, MD has received a total of $66,648 in payments from pharmaceutical and medical device companies, with $791.07 received in 2024. These payments were reported across 281 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($29,900).
As a Medicare-enrolled provider, Savetsky has provided services to 1,478 Medicare beneficiaries, totaling 2,017 services with total Medicare billing of $119,399. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Cornea and External Diseases Specialist
- Other Specialties Cornea and External Diseases Specialist
- Location Culver City, CA
- Active Since 05/21/2008
- Last Updated 06/28/2023
- Taxonomy Code 207WX0120X
- Entity Type Individual
- NPI Number 1255598819
Products in Payments
- DEXYCU (Drug) $41,853
- TYRVAYA (Drug) $9,987
- ACTHAR (Biological) $8,668
- XIIDRA (Drug) $1,035
- ForeseeHome (Device) $909.85
- Prokera (Device) $668.30
- Cequa (Drug) $332.69
- XDEMVY (Drug) $295.19
- TEPEZZA (Biological) $245.99
- TEPEZZA (Drug) $183.37
- OXERVATE (Drug) $162.90
- HYDRUS Microstent (Device) $149.63
- ENVISTA (Device) $147.21
- STELLARIS (Device) $145.09
- STAR S4 IR Excimer Laser system (Device) $142.26
- Tecnis 1-piece IOL (Device) $122.00
- iSTENT iNJECT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $118.04
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $117.78
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $100.00
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $98.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.